HEALTHCO HEALTHCARE & WELLNESS REIT (HCW)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

HCW - HEALTHCO HEALTHCARE & WELLNESS REIT

FNArena Sector : REITs
Year End: June
GICS Industry Group : Real Estate
Debt/EBITDA: 13.4
Index: ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.125

22 Apr
2024

0.025

OPEN

$1.10

2.27%

HIGH

$1.14

2,304,092

LOW

$1.10

TARGET
$1.565 39.1% upside
Franking for last dividend paid out: 0%
OTHER COMPANIES IN THE SAME SECTOR
ABG . AOF . ARF . ASK . BWP . CDP . CDP . CHC . CIP . CLW . COF . CQE . CQR . DXC . DXI . DXS . ECF . GDF . GDI . HDN . NPR . NSR . PLG . REP . RFF . RGN . SCG . TGP . URW . VCX . WOT . WPR .
FNARENA'S MARKET CONSENSUS FORECASTS
HCW: 1
Title FY22
Actual
FY23
Actual
FY24
Forecast
FY25
Forecast
EPS (cps) xxx N/A 7.9 xxx
DPS (cps) xxx N/A 8.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 15.1 xxx
Dividend Yield xxx N/A 6.7% xxx
Div Pay Ratio(%) xxx N/A 102.0% xxx

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

N/A

Estimated Dividend Growth
(Average Of Past Three Years)

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 27/03 - ex-div 2c (franking 0%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 2023
EPS Basic 5.4
DPS All 7.6
Sales/Revenue 49.1 M
Book Value Per Share 169.0
Net Operating Cash Flow 11.1 M
Net Profit Margin 41.14 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 2023
Return on Capital Employed 2.52 %
Return on Invested Capital 1.73 %
Return on Assets 1.67 %
Return on Equity 2.52 %
Return on Total Capital 4.49 %
Free Cash Flow ex dividends -18.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 2023
Short-Term Debt -
Long Term Debt 704 M
Total Debt 704 M
Goodwill - Gross -
Cash & Equivalents - Generic 8 M
Price To Book Value 0.78

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 2023
Capex -
Capex % of Sales -
Cost of Goods Sold 16 M
Selling, General & Admin. Exp & Other -19 M
Research & Development -
Investments - Total 1,647 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.8

No. Of Recommendations

4
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Bell Potter

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

14/02/2024

1

Outperform

$1.45

28.89%

HealthCo Healthcare & Wellness REIT's funds from operations were broadly in line with Macquarie and guidance is reaffirmed.

At 42%, look-through gearing at end-December offers limited capacity for deployment into developments, the broker notes, but progress on divestments will assist the REIT's capacity.

The earnings growth outlook remains attractive, Macquarie suggests, given a long WALE portfolio, CPI-linked leases and protection to changes in interest rates.

Easing its expectations for Camden stage 2, the broker cuts its target to $1.45 from $1.48. Outperform retained.

FORECAST
Macquarie forecasts a full year FY24 dividend of 8.10 cents and EPS of 7.60 cents.
Macquarie forecasts a full year FY25 dividend of 8.20 cents and EPS of 8.10 cents.

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

HCW STOCK CHART